✦ LIBER ✦

Cardiovascular Function in Nonclinical Drug Safety Assessment: Current Issues and Opportunities

✍ Scribed by Sarazan, R. D.; Mittelstadt, S.; Guth, B.; Koerner, J.; Zhang, J.; Pettit, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Integrated and translational nonclinical

✍ Berridge, Brian R.; Hoffmann, Peter; Turk, James R.; Sellke, Frank; Gintant, Gar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Best practice in the conduct of key nonc

✍ D.J. Leishman; T.W. Beck; N. Dybdal; D.J. Gallacher; B.D. Guth; M. Holbrook; B. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 484 KB

Drug safety assessment in clinical trial

✍ Sonal Singh, Yoon K Loke 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 249 KB

Predictive ADMET (Integrative Approaches

✍ Wang, Jianling; Urban, Laszlo 📂 Article 📅 2014 🏛 John Wiley & Sons, Inc. ⚖ 413 KB

Circulating MicroRNAs in Drug Safety Ass

✍ Osaki, Mitsuhiko; Kosaka, Nobuyoshi; Okada, Futoshi; Ochiya, Takahiro 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 286 KB

Zebrafish (Methods for Assessing Drug Sa

✍ McGrath, Patricia 📂 Article 📅 2011 🏛 John Wiley & Sons, Inc. ⚖ 180 KB